← All CategoriesAPI Portfolio

General APIs

Broad-spectrum APIs spanning CNS, cardiovascular, urology, and metabolic indications — plus enzyme and biologic preparations. Supplied in pharmaceutical grade for diverse formulation manufacturing across primary and specialty care product lines.

Regulatory ReadyCOA, DMF & CEP supportUSP / EP / BPPharmacopoeial grade APIsFull TraceabilityBatch-to-batch documentation

Request General API Catalogue

All General APIs

44 APIs available

Page 1 of 3

CAS 59-66-5 Product Code GEN-001 WHO-GMP

Acetazolamide

Carbonic anhydrase inhibitor in USP/EP grade for oral tablet formulation manufacturing. Sourced for glaucoma, altitude sickness, and oedema product lines.

USP EP Oral

CAS 28981-97-7 Product Code GEN-002 WHO-GMP

Alprazolam

Triazolobenzodiazepine in USP/EP grade for oral tablet formulation manufacturing. Sourced for anxiety and panic disorder product lines. Note: controlled substance — Schedule IV in most jurisdictions.

USP EP Oral Injection

CAS 344423-98-9 Product Code GEN-003 WHO-GMP

Atorvastatin Calcium

HMG-CoA reductase inhibitor (statin) supplied as calcium salt — USP/EP grade — for oral tablet formulation manufacturing. Sourced for hypercholesterolaemia and cardiovascular risk reduction product lines.

USP EP Oral

CAS 58-08-2 Product Code GEN-004 WHO-GMP

Caffeine Anhydrous

Xanthine alkaloid in USP/EP/BP/JP grade for tablet and injectable formulation manufacturing. Sourced for analgesic-adjunct and CNS stimulant product lines.

USP EP BP JP Oral Injection

CAS 58551-69-2 Product Code GEN-005 WHO-GMP

Carboprost Tromethamine

Prostaglandin F2-alpha analogue supplied as tromethamine salt — USP grade — for sterile injectable formulation manufacturing. Sourced for postpartum haemorrhage and abortifacient product lines.

USP Injection

CAS 78-44-4 Product Code GEN-006 WHO-GMP

Carisoprodol

Centrally-acting skeletal muscle relaxant in USP/EP grade for oral tablet formulation manufacturing. Sourced for acute musculoskeletal pain product lines.

USP EP Oral

CAS 113-92-8 Product Code GEN-007 WHO-GMP

Chlorpheniramine Maleate

First-generation antihistamine in USP grade for tablet and syrup formulation manufacturing. Sourced for cold/cough combination and allergy product lines.

USP Oral

CAS 987-78-0 (base) / 33818-15-4 (sodium) Product Code GEN-008 WHO-GMP

Citicoline

Nootropic nucleotide supplied as free base and sodium salt for capsule, oral solution, and injectable formulation manufacturing. Sourced for neuroprotection and stroke-recovery product lines.

Oral Injection

CAS 41354-29-4 (HCl) Product Code GEN-009 WHO-GMP

Cyproheptadine

H1/serotonin antagonist supplied as hydrochloride sesquihydrate — the standard trading form — for tablet and paediatric syrup formulation manufacturing. Sourced for allergy and appetite-stimulation product lines.

Oral

CAS 6700-34-1 Product Code GEN-013 WHO-GMP

Dextromethorphan HBr (DMR)

Non-opioid antitussive bromide salt in USP grade for syrup, tablet, and lozenge formulation manufacturing. Sourced for cough-suppressant product lines.

USP Oral

CAS 15307-79-6 / 15307-81-0 Product Code GEN-010 WHO-GMP

Diclofenac Sodium / Potassium

Phenylacetic acid NSAID supplied as sodium and potassium salts — distinct compounds, USP/EP/BP/IP grade — for tablet and injectable formulation manufacturing.

USP EP BP IP Oral Injection

CAS 57808-66-9 Product Code GEN-011 WHO-GMP

Domperidone Powder / Pellets

Dopamine D2/D3 antagonist supplied as raw powder and enteric pellets — same compound, IP/BP/USP grade — for antiemetic and prokinetic tablet/suspension formulation manufacturing.

IP BP USP Oral

CAS 69975-86-6 Product Code GEN-012 WHO-GMP

Doxophylline

Xanthine bronchodilator in USP/EP/BP/IP grade for tablet and injectable formulation manufacturing, with a better cardiovascular/CNS safety profile than theophylline.

USP EP BP IP Oral Injection

CAS 679809-58-6 Product Code GEN-015 WHO-GMP

Enoxaparin Sodium

Low molecular weight heparin biologic/semisynthetic, derived from porcine intestinal mucosa, for subcutaneous injectable formulation manufacturing. Sourced for DVT/PE prophylaxis product lines — requires biologic-grade QA systems.

Injection

CAS 202409-33-4 Product Code GEN-014 WHO-GMP

Etoricoxib

Selective COX-2 inhibitor in USP/EP/BP/IP grade for oral tablet formulation manufacturing. Sourced for osteoarthritis and acute gout product lines.

USP EP BP IP Oral

CAS 163222-33-1 Product Code GEN-016 WHO-GMP

Ezetimibe

Selective cholesterol absorption inhibitor in USP grade for oral tablet formulation manufacturing, often paired with statins. Sourced for hypercholesterolaemia product lines.

USP Oral

CAS 24808-52-4 Product Code GEN-017 WHO-GMP

Ferrous Ascorbate

Iron-vitamin C chelate haematinic in IP grade for tablet, syrup, and powder formulation manufacturing, offering faster absorption with fewer GI effects than ferrous sulfate.

IP Oral

CAS 3717-88-2 (HCl) Product Code GEN-018 WHO-GMP

Flavoxate

Anticholinergic urinary antispasmodic supplied as hydrochloride salt — USP/EP/BP grade — for oral tablet formulation manufacturing. Sourced for dysuria and cystitis-symptom product lines.

USP EP BP Oral

CAS 54-31-9 Product Code GEN-019 WHO-GMP

Frusemide

Loop diuretic identical to furosemide (alternate non-US spelling, same CAS) in USP/EP/BP grade for tablet, injectable, and oral solution formulation manufacturing.

USP EP BP Oral Injection

CAS Activity-defined, no fixed CAS Product Code GEN-020 WHO-GMP

Fungal Diastase

Alpha/beta-amylase enzyme preparation from Aspergillus oryzae for digestive-enzyme formulation manufacturing. Note: defined by activity units (U/g), not molecular CAS — requires enzyme-grade QA documentation.

WHO-GMP Certified Sources

Global Delivery

Regulatory Support

Consistent Quality

Secure Packaging / Custom Options